The new acrylic acid unit will have a capacity of 90,000 tons per year, while the new butyl acrylate unit will have a capacity of 150,000 tons per year.
The company has recently forayed into marketing and sale of own branded pesticides which has provided it a revenue diversity.
The company is investing in Oberhausen to increase delivery capability, digitalisation, organisational efficiency, and automation.
The Period of Investigation is from October 2019 to September 2020.
Startup is planned for the fourth quarter in 2021 and will mainly support customers in the Asia Pacific region
Acquisition enhances Aceto’s ability to support customers through all stages of product development
The company might not be able to meet its contractual agreements until the end of the first quarter of 2021.
Amyris is licensing to DSM rights to assume the supply of Farnesene to Givaudan for the production and sale of a single specialty ingredient.
The new chlor-alkali production complex to yield 30,000 tons/yr of 32% caustic soda.
The key to the future lies with cloud service automation.
50% of the critical APIs are being imported and almost all the imports are from China.
The idea is to extend the reach to these communities and provide them with healthcare facilities and improve the quality of life of all individuals.
If the split-off is not fully subscribed, the remaining shares of N&B common stock will be distributed through a pro rata spin-off to DuPont stockholders.
With the new pre-polymer reactor technology, the ASEAN Technical Center strengthens and complements BASF’s technical support network in China, Korea, and Germany.
The new sugar mill will have capacities - Sugar of 10,000; TCD Power of 47.50 MW and Ethanol of 230 KLPD.
Indian Chemical News (ICN) is organizing its next E-conference on "Making India a Global Agrochemical Manufacturing Hub" on 22nd December from 3:00 - 4:30 PM IST with participation from all stakeholders including Government, academia, start-ups, farmers, industry associations and local as well as global companies
Pharmaceuticals export from India is expected to cross 25 billion dollars this fiscal.
Kemira will be the exclusive provider of the new biomaterials to its core markets
The COVID-19 crisis has also demonstrated how collaboration in international value chains can drive value instead of risks.
The transaction is expected to close in the first half of 2021, subject to the approval of the relevant competition authorities.
Subscribe To Our Newsletter & Stay Updated
